Concepedia

Yixuan Liu

YL

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2022

Affiliations

Peking University(Current)

Yixuan Liu is an author at Peking University specializing in cancer immunotherapy, immunology, and checkpoint inhibitor therapy.

ORCID

Publications per year

2022–2025

3

Publications

3

Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy

Peishan Li, Ying Xie, Jinling Wang et al. · Bioactive Materials · 2024 · 21 citations · Full text

, , +17

A protease-cleavable liposome for co-delivery of anti-PD-L1 and doxorubicin for colon cancer therapy in mice

Yixuan Liu, Ying Xie, Yuling Chen et al. · Nature Communications · 2025 · 21 citations · Full text

, , +17

Prognostic Perspectives of STING and PD-L1 Expression and Correlation with the Prognosis of Epstein-Barr Virus-Associated Gastric Cancers

Qi Sun, Yao Fu, Xiaobing Chen et al. · Gut and Liver · 2022 · 15 citations · Full text

, , +17

1–3 of 3